Evaluatation of a Microcurrent + Cold Therapy Device

An 8 Week Randomized, Crossover Study to Evaluate the Efficacy of a Microcurrent + Cold Therapy Device

The present study aims to assess use of a microcurrent and cryotherapy device on skin health over an 8-week period using an at-home device that provides 15-minutes of microcurrent + cold therapy once daily. An additional aim is to assess the acute (i.e., single) use of microcurrent or microcurrent + cold therapy on measures of skin health. The primary question it seeks to answer is whether daily use of the TheraFace Pro Gen 2 alters facial skin characteristics. Secondary aims include collecting clinical images, professional photographs, and consumer perceptions of the device.

Participants between the ages of 25-65 with various skin types will be enrolled for participation. Participants will visit the clinic three times for collection of outcome metrics at baseline with microcurrent therapy, baseline 2 using microcurrent + cold therapy, and 8 weeks after baseline. Measurements include: expert clinical grading, digital imaging, subjective assessment of skin, and clinical grade-images.

Study Overview

• Status: Enrolling by invitation
• Conditions: Skin Health
• Intervention / Treatment: Device: Acute Microcurrent Treatment; Device: Acute Microcurrent + cold therapy; Device: 8-week Chronic Use of Microcurrent + Cold Therapy

Detailed Description

At home treatments to minimize and/or reverse the effects of skin aging has been gaining popularity over time. Two treatments commonly used in spa-settings to achieve these goals are microcurrent therapy and cold-therapy. Microcurrent therapy is a gentle skin treatment that uses low-level voltage to stimulate the facial muscles. This low-level voltage is applied during microcurrent facials to help tone and firm the skin by causing subtle muscle contractions. Localized cold therapy helps reduce inflammation by narrowing blood vessels and decreasing blood flow to the treated area. The central aim of this study is to investigate both acute and chronic (8 weeks) use of an at-home device that delivers both microcurrent and cold therapy on skin health. Participants will complete two acute baseline visits in randomized order, microcurrent alone and microcurrent + cold therapy in order to assess the acute effects of this therapy. Participants will then complete 8-weeks of microcurrent + cold therapy lasting about 8 minutes/day using the Therabody TheraFace Pro Gen 2 at home. Outcome measures include expert assessment and participant subjective health of skin of the face.

• Study Type: Interventional
• Enrollment (Estimated): 100
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • New Jersey
    • Teaneck, New Jersey, United States, 07666
      • Validated Claim Support

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Subject is female or male (approximately 85% female and 15% male)
• Subject is between the ages of 25-65 (no more than 25% 55-65 per group)
• Individuals with fine lines/wrinkles, lack of firmness, dullness, and uneven skin tone with a grade of at least 3 on a 10-point scale.
• Individuals with sensitive skin.
• Individuals who are able to cooperate with the Principal Investigator and study personnel throughout the duration of the study and are willing to comply with all study procedures, methods, evaluations, and study product use.
• Individuals who are able to read and sign and informed consent.
• Individuals who are able to receive emails on their cellular phones and are capable of completing electronic Informed Consents and/or Questionnaires on their device.
• Individuals willing to be photographed and sign a model release.

Exclusion Criteria:

• Individuals who have had Botox in the last 3 months prior to Baseline.
• Individuals who have had Filler (Including Lip Filler) in the last 6 months prior to Baseline.
• Individuals with a history of atopic eczema, psoriasis, or onychomycosis.
• Individuals who have used a topical or system medication within 14 days prior to Baseline.
• Individuals who are on anti-acne drugs, topical and/or oral retinoids.
• Individuals currently on GLP1 medications or other weight loss regimens.
• Individuals who have used a beauty device of any kind in a clinical testing facility in the past 5 months prior to Baseline.
• Individuals who have used self-tanners and/or tanning beds within 14 days prior to Baseline.
• Individuals currently participating in other clinical studies that are testing a face product and/or device.
• Individuals with uncontrolled medical condition(s), including dermatological problems, which could put them at risk in the opinion of the Principal Investigator or compromise the study outcome and/or chronic or serious diseases and conditions which would prevent participation in this clinical study such as cancer, AIDS, insulin-dependent diabetes, renal impairment, mental illness, and/or drug/alcohol addiction.
• Individuals with a history of melanoma, or a treated skin cancer within the last 5 years.
• Individuals who are pregnant, lactating, or planning to become pregnant. -Individuals who become pregnant during the study must inform the Principal Investigator immediately.
• Individuals who are unreliable or unlikely to be available for the duration of the study.
• Individuals with a history of allergic reactions, skin sensitization and/or known allergies to cosmetic and personal care products/ingredients.
• Individuals who are immunocompromised.
• Individuals who are employees of VCS, other testing firms/laboratories, consumer products, and/or raw goods manufacturers/suppliers.
• Individuals who are unable to communicate or cooperate with the Principal Investigator/study personnel due to language problems, poor mental development, or impaired cerebral function.
• Individuals who started hormones within the last three months preceding the commencement of the study.
• Individuals who are using oral contraception for less than three months before study commencement or who have changed their contraceptive method within the three months before the Baseline visit or planning to modify their contraception treatment within the duration of the study.
• Individuals who have regular salon and/or dermatological procedures that can interfere with study results (Microdermabrasion, Fillers, Facial Peels, etc.) and are not willing to stop throughout the study.
• Individuals with facial tattoos and facial piercings (that can't be removed).
• Individuals with tattooed/permanent make up (i.e., eyeliner, eyebrows, lip liner, etc.), eyebrow microblading, and/or eyelash extensions.
• Individuals who plan to change their hairstyle throughout the course of the study or who wear hair coverings regularly (i.e., wigs, coloring, extensions, etc.).

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Acute Application of Microcurrent by Esthetician; A licensed esthetician will complete an 18-step routine on the right and left side of the face including: lower neck (glide), upper neck (glide), vertical neck (glide), neck contour (glide), neck contour (press + hold), jawline cradle (glide), jawline cradle (press + hold), jaw contour (glide), jaw contour (press + hold), cheek contour (glide), cheek contour (press + hold), cheekbone contour (glide), cheek contour (press + hold), brow lift (glide), brow lift (press + hold), eye contour (glide), eye contour (press + hold), inner brow (glide), & inner brow (press + hold).	Device: Acute Microcurrent Treatment; The esthetician will apply only the microcurrent setting during the 18-step routine.; Device: Acute Microcurrent + cold therapy; The esthetician will apply cold + microcurrent therapy during the 18-step routine.
Experimental: Chronic Use of Microcurrent + Cold Therapy; All evaluations will occur after sitting in 15-minutes of ambient conditions. Participants will be instructed to use the TheraFace Pro Gen 2 for approximately 8 minutes a day following an 18-step routine on each side of the face. The steps include: ower neck (glide), upper neck (glide), vertical neck (glide), neck contour (glide), neck contour (press + hold), jawline cradle (glide), jawline cradle (press + hold), jaw contour (glide), jaw contour (press + hold), cheek contour (glide), cheek contour (press + hold), cheekbone contour (glide), cheek contour (press + hold), brow lift (glide), brow lift (press + hold), eye contour (glide), eye contour (press + hold), inner brow (glide), & inner brow (press + hold). Each location will receive ~10 seconds of treatment.	Device: 8-week Chronic Use of Microcurrent + Cold Therapy; Participants will be instructed to use the TheraFace Pro Gen 2 for approximately 8 minutes a day following an 18-step routine on each side of the face. The steps include: ower neck (glide), upper neck (glide), vertical neck (glide), neck contour (glide), neck contour (press + hold), jawline cradle (glide), jawline cradle (press + hold), jaw contour (glide), jaw contour (press + hold), cheek contour (glide), cheek contour (press + hold), cheekbone contour (glide), cheek contour (press + hold), brow lift (glide), brow lift (press + hold), eye contour (glide), eye contour (press + hold), inner brow (glide), & inner brow (press + hold). Each location will receive ~10 seconds of treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Expert grading	Expert clinical grading will be used to measure a variety of skin health appearance measures including: fine lines/wrinkles, firmness, elasticity, radiance plumping (lips), contour (cheeks), pore appearance, lift (mid-face and jowls), nasolabial folds, and skin tone evenness. These will be graded on a scale from 0 to 10, with 0 representing a positive outcome (i.e., no wrinkles) and 10 representing a negative outcome (i.e., numerous, deep wrinkles). These will be assessed by an expert grader.	8-weeks
Cutometer	The Cutometer MPA 580 measures the viscoelastic properties of the skin using suction and a probe to determine the penetration depth using an optical measuring system. The resistance of the skin to be sucked up by the negative pressure (firmness) and its ability to return to its original position (elasticity) are calculated and displayed as curves. The Cutometer outputs include many parameters of different portions of the measurement curve including R0 (Uf, firmness), R2 (Ua/Uf, gross elasticity), R5 (Ur/Ue, net elasticity), R7 (Ur/Uf, elastic portion) and R9 (R3[last max amp]-R0[Uf], fatigue). Elasticity will be reported using the R5 (Ur/Ue) parameter, as the skin becomes more elastic this value will increase. Skin Firmness will be reported using the R0 (Uf) parameter, as the skin becomes firmer this value will decrease. R0 (elasticity) and R5 (firmness) will be the only two parameters provided.	8 weeks
VISIA CR Imaging	The VISIA-CR is a clinical facial imaging system used to analyze skin conditions. Images are taken in a variety of lighting conditions (Standard 1, Raked, Cross Polarized, and Primos 3D) to assess wrinkle depth and texture. Images will be taken of the face, utilizing the following angles: 45 degrees right, straight on, and 45 degrees left with the following lighting conditions: Standard 1, Raked, Cross Polarized, and Primos 3D. Analysis is performed by Canfield. The VISIA-CR provides a percentile value compared to others with similar skin (the higher the better); the feature count (the lower the better) and the absolute score (the lower the better).	8 weeks
Clinical Photography	Clinical photography involves analysis of high-resolution images taken at different angles (45 degrees right, straight on, 45 degrees left) to compare in a side-by-side format at each time point. Images at each time point will be compared to highlight key changes in skin condition.	8 weeks
Participant perceptions of skin health	Participants will complete subjective questionnaires ranking the impact of the treatment on overall skin health measures, including: finelines, facial puffiness, bounce, resiliency, sculpting of jawline, firmness, lift, plumping (lips), texture, comfort, plumpness, facial contour, rejuvenation, skin tone, sagging skin, and liveliness. Participants will also rank enjoyment, convenience, ease of use, and comfort of device usage. All measures will be ranked on a 5-point Likert scale, with 0 indicating strongly disagree and 5 indicating strongly agree.	8 weeks

Collaborators and Investigators

• Sponsor: Therabody, Inc.
• Collaborators: Validate Claim Support

Study record dates

Study Major Dates

• Study Start (Estimated): April 1, 2026
• Primary Completion (Estimated): May 31, 2026
• Study Completion (Estimated): June 30, 2026

Study Registration Dates

• First Submitted: March 26, 2026
• First Submitted That Met QC Criteria: April 1, 2026
• First Posted (Actual): April 3, 2026

Study Record Updates

• Last Update Posted (Actual): April 3, 2026
• Last Update Submitted That Met QC Criteria: April 1, 2026
• Last Verified: April 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Therapeutics; Cryotherapy
• Other Study ID Numbers: PR251054.V03

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: Yes
• product manufactured in and exported from the U.S.: No